PDL BIOPHARMA INC's ticker is PDLI and the CUSIP is 69329Y104. A total of 187 filers reported holding PDL BIOPHARMA INC in Q4 2017. The put-call ratio across all filers is 2.92 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $2,015,000 | +80.9% | 735,307 | +123.8% | 0.10% | +121.7% |
| Q3 2017 | $1,114,000 | +39.4% | 328,619 | +1.5% | 0.05% | +53.3% |
| Q2 2017 | $799,000 | +8.7% | 323,608 | 0.0% | 0.03% | +11.1% |
| Q1 2017 | $735,000 | +7.1% | 323,608 | +0.0% | 0.03% | 0.0% |
| Q4 2016 | $686,000 | -84.3% | 323,467 | -28.1% | 0.03% | -84.9% |
| Q2 2014 | $4,356,000 | +11.6% | 450,047 | -4.1% | 0.18% | +9.1% |
| Q1 2014 | $3,902,000 | -5.8% | 469,514 | -4.3% | 0.16% | +1.2% |
| Q4 2013 | $4,141,000 | +14.6% | 490,600 | +8.3% | 0.16% | +2.5% |
| Q3 2013 | $3,612,000 | +3.3% | 453,163 | +0.1% | 0.16% | -10.2% |
| Q2 2013 | $3,496,000 | – | 452,878 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Argent Trust Co | 41,405 | $102,270 | 0.01% |
| Diversified Trust Co | 11,029 | $26,469 | 0.00% |
| HANCOCK WHITNEY CORP | 128,396 | $0 | 0.00% |
| RHUMBLINE ADVISERS | 612 | $1,511 | 0.00% |
| Ancora Advisors LLC | 4,948 | $0 | 0.00% |
| Westside Investment Management, Inc. | 500 | $0 | 0.00% |